NeuroPace (NPCE) Cash from Investing Activities (2020 - 2026)

NeuroPace (NPCE) recorded quarterly Cash from Investing Activities of -$117000.0 in Q1 2026, down 20.62% quarter-over-quarter from -$97000.0 in Q4 2025, and down 216.22% on a YoY basis from $100674.4 in Q1 2025.

NeuroPace (NPCE) Cash from Investing Activities (2020 - 2026) Analysis & Trends

NeuroPace's Cash from Investing Activities history runs 7 years deep, the most recent figure standing at -$117000.0 for Q1 2026.

  • In Q1 2026, Cash from Investing Activities fell 216.22% year-over-year to -$117000.0; the TTM figure through Mar 2026 stood at -$412000.0 (down 106.28% YoY), while the FY2025 annual figure was -$332000.0, down 103.69% from the prior year.
  • Cash from Investing Activities was -$117000.0 for Q1 2026 at NeuroPace, down from -$97000.0 in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $10.1 million in Q1 2023 to a low of -$306000.0 in Q1 2022.
  • Historically, Cash from Investing Activities has averaged $3.3 million across 5 years, with a median of $2.4 million in 2024.
  • The sharpest annual moves came in 2022 and 2026: Cash from Investing Activities surged 5877.92% in 2022, then plunged 216.22% in 2026.
  • A 5-year view of Cash from Investing Activities shows it stood at $8.9 million in 2022, then sank by 61.02% to $3.5 million in 2023, then sank by 43.45% to $2.0 million in 2024, then slumped by 104.95% to -$97000.0 in 2025, then retreated by 20.62% to -$117000.0 in 2026.
  • The last three Cash from Investing Activities figures came in at -$117000.0 (Q1 2026), -$97000.0 (Q4 2025), and -$30000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn -20.32 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn -185.00 Mn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn -816.00 Mn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn -591.00 Mn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn -92.80 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -475.32 Mn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn -298.50 Mn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn -2.50 Bn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn -217.20 Mn
10 NeuroPace 527.50 Mn 473.52 Mn 18.05 Mn -117,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -117,000.00
Mar 31, 2026 -117,000.00
Dec 31, 2025 -97,000.00
Dec 31, 2025 -97,000.00
Sep 30, 2025 -30,000.00
Sep 30, 2025 -30,000.00
Jun 30, 2025 -168,000.00
Jun 30, 2025 -168,000.00
Mar 31, 2025 -37,000.00
Mar 31, 2025 -37,000.00
Dec 31, 2024 1.96 Mn
Dec 31, 2024 1.96 Mn
Sep 30, 2024 1.40 Mn
Sep 30, 2024 1.40 Mn
Jun 30, 2024 3.24 Mn
Jun 30, 2024 3.24 Mn
Mar 31, 2024 2.40 Mn
Mar 31, 2024 2.40 Mn
Dec 31, 2023 3.47 Mn
Dec 31, 2023 3.47 Mn